RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+2.88%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$292M
AUM Growth
+$292M
(+6.3%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
10.13%
Top 10 Holdings %
Top 10 Hldgs %
72.73%
Holding
39
New
5
Increased
13
Reduced
10
Closed
3
Top Buys
| 1 |
BLUE
bluebird bio
BLUE
|
$16.7M |
| 2 |
SPDR Gold Trust
GLD
|
$10.5M |
| 3 |
Bristol-Myers Squibb
BMY
|
$7.36M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$5.64M |
| 5 |
VIVE
VIVEVE MED INC
VIVE
|
$3.34M |
Top Sells
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$7.54M |
| 2 |
Omeros
OMER
|
$3.84M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
$2.9M |
| 4 |
Lipocine
LPCN
|
$2.44M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$1.88M |
Sector Composition
| 1 | Healthcare | 81.34% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alnylam Pharmaceuticals
ALNY
$58.5B
| $46.2M | 15.78% | 832,549 -33,830 | -4% | -$1.88M |
|
2
Incyte
INCY
$16.5B
| $31.4M | 10.72% | 392,236 +12,821 | +3% | +$1.03M |
|
|
BLUE
3
DELISTED
bluebird bio
BLUE
| $26.5M | 9.05% | 612,025 +385,654 | +170% | +$16.7M |
|
|
ACHN
4
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $18.9M | 6.46% | 2,424,136 -134,723 | -5% | -$1.05M |
|
|
LJPC
5
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $18.8M | 6.43% | 1,176,146 +7,081 | +0.6% | +$113K |
|
|
AVXS
6
DELISTED
AveXis, Inc. Common Stock
AVXS
| $18.1M | 6.19% | 476,367 +2,993 | +0.6% | +$114K |
|
|
7
Bristol-Myers Squibb
BMY
$96B
| $15.4M | 5.27% | 209,701 +100,000 | +91% | +$7.36M |
|
|
KITE
8
DELISTED
Kite Pharma, Inc.
KITE
| $14.3M | 4.88% | 285,518 -57,985 | -17% | -$2.9M |
|
|
SSRG
9
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $12.1M | 4.14% | 922,215 +2,535 | +0.3% | +$33.3K |
|
|
10
SPDR Gold Trust
GLD
$107B
| $10.5M | 3.59% | +83,000 | New | +$10.5M |
|
11
Atara Biotherapeutics
ATRA
$84.6M
| $10.5M | 3.58% | 465,874 -7,252 | -2% | -$163K |
|
|
AGEN
12
Agenus
AGEN
$133M
| $9.84M | 3.36% | 2,429,149 +14,625 | +0.6% | +$59.2K |
|
13
BioCryst Pharmaceuticals
BCRX
$1.74B
| $6.35M | 2.17% | 2,237,066 +263,134 | +13% | +$747K |
|
14
iShares 20+ Year Treasury Bond ETF
TLT
$47.8B
| $6.25M | 2.14% | 45,000 +15,000 | +50% | +$2.08M |
|
|
DRNA
15
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $6.08M | 2.08% | 2,026,894 | – | – |
|
|
ICPT
16
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.64M | 1.93% | +39,500 | New | +$5.64M |
|
17
Celldex Therapeutics
CLDX
$1.47B
| $5.55M | 1.9% | 1,264,227 +274,851 | +28% | +$1.21M |
|
|
18
Omeros
OMER
$283M
| $5.54M | 1.89% | 526,788 -364,734 | -41% | -$3.84M |
|
|
VIVE
19
DELISTED
VIVEVE MED INC
VIVE
| $3.34M | 1.14% | +814,946 | New | +$3.34M |
|
|
JO
20
DELISTED
iPath Bloomberg Coffee Subindex Total Return ETN due June 24, 2038
JO
| $3.19M | 1.09% | +144,200 | New | +$3.19M |
|
|
CORI
21
DELISTED
Corium International, Inc.
CORI
| $2.96M | 1.01% | 852,961 +24,629 | +3% | +$85.5K |
|
|
IVTY
22
DELISTED
Invuity, Inc
IVTY
| $2.15M | 0.74% | 226,042 +13,234 | +6% | +$126K |
|
23
Regenxbio
RGNX
$451M
| $1.94M | 0.66% | 242,784 +1,461 | +0.6% | +$11.7K |
|
|
FPRX
24
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.85M | 0.63% | 44,701 -182,297 | -80% | -$7.54M |
|
|
GBT
25
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.61M | 0.55% | 97,138 -93,843 | -49% | -$1.56M |
|